(54) found that Glypican-1 (GPC1), a cell surface proteoglycan, was specifically enriched in tumor cell-derived exosomes, and GPC1+ exosomes in the serum served as a non-invasive diagnostic and screening biomarker with absolute sensitivity and specificity (AUC = 1.0). The gene discussed is GPC1; the disease is neoplasm.